Baolingbao Biology Co Ltd
SZSE:002286
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Baolingbao Biology Co Ltd
SZSE:002286
|
CN |
|
S
|
Super Copper Corp
CNSX:CUPR
|
CA |
|
H
|
Haba Laboratories Inc
TSE:4925
|
JP |
|
Mirada PLC
LSE:MIRA
|
UK |
|
S
|
Super Hi International Holding Ltd
HKEX:9658
|
SG |
|
D
|
Destiny Tech100 Inc
NYSE:DXYZ
|
US |
|
M
|
Meriaura Group Oyj
STO:MERIS
|
FI |
|
E
|
Enaex SA
SGO:ENAEX
|
CL |
|
Turk Hava Yollari AO
IST:THYAO.E
|
TR |
|
Maximus Resources Ltd
ASX:MXR
|
AU |
|
N
|
Ningbo Fujia Industrial Co Ltd
SSE:603219
|
CN |
|
T
|
Toyam Industries Ltd
BSE:538607
|
IN |
|
Z
|
Zhejiang Baida Precision Manufacturing Corp
SSE:603331
|
CN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Baolingbao Biology Co Ltd's stock price target?
Not Available
Baolingbao Biology Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Baolingbao Biology Co Ltd's Revenue forecast?
Projected CAGR
2%
For the last 13 years the compound annual growth rate for Baolingbao Biology Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 2%.
What is Baolingbao Biology Co Ltd's Operating Income forecast?
Projected CAGR
6%
For the last 13 years the compound annual growth rate for Baolingbao Biology Co Ltd's operating income is 6%. The projected CAGR for the next 3 years is 6%.
What is Baolingbao Biology Co Ltd's Net Income forecast?
Projected CAGR
10%
For the last 13 years the compound annual growth rate for Baolingbao Biology Co Ltd's net income is 5%. The projected CAGR for the next 3 years is 10%.
